HIV-1 vaccine candidate evaluation in non-human primates

被引:7
|
作者
Lu, YC [1 ]
机构
[1] Inst Int Vaccine Dev Inc, Cambridge, MA 02138 USA
来源
CRITICAL REVIEWS IN ONCOGENESIS | 1997年 / 8卷 / 2-3期
关键词
AIDS vaccine efficacy; HIV-1 vaccine candidates; non-human primates; animal models; recombinant HIV-1 gp120; whole inactivated virus; recombinant viral vectors; recombinant BCG vectors;
D O I
10.1615/CritRevOncog.v8.i2-3.50
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of an HIV-1 vaccine in the last 13 years from an industrial point of view has focused on evaluating potential vaccine candidates in non-human primates. This review discusses the HIV-1 vaccine candidates that have been tested in chimpanzees or monkeys and includes those based on recombinant gp120, recombinant gp160, different viral and bacterial vectors expressing gp120, gp160, or only V3 peptide, naked DNA vaccines, and whole inactivated viruses. To help understand the result of efficacy studies in chimpanzees and monkeys, information regarding the challenge viruses used in these studies is also included. The review does not discuss the testing of SIV-related vaccines or the testing of HIV-1 vaccine candidates in other animal species other than non-human primates.
引用
收藏
页码:273 / 291
页数:19
相关论文
共 50 条
  • [1] Novel Adeno-Associated Viruses as Vaccine Carriers for HIV-1: Evaluation in Non-Human Primates
    Calcedo, Roberto
    Zhi, Yan
    Figueredo, Joanita M.
    Franco, Judith I.
    Johnston, Julie C.
    Grant, Rebecca L.
    Wilson, James M.
    MOLECULAR THERAPY, 2006, 13 : S234 - S235
  • [2] Evaluation Of Immunogenicity Of A Pneumocystis Recombinant Protein Vaccine Candidate, Kexin, In Non-Human Primates
    Kling, H. M.
    Guyach, S. E.
    Tarantelli, R.
    Burton, A.
    McManus, A.
    Norris, K. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [3] B-Cells and the Use of Non-Human Primates for Evaluation of HIV Vaccine Candidates
    Demberg, Thorsten
    Robert-Guroff, Marjorie
    CURRENT HIV RESEARCH, 2015, 13 (06) : 462 - 478
  • [4] Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
    Cai, Fangping
    Chen, Wei-Hung
    Wu, Weimin
    Jones, Julia A.
    Choe, Misook
    Gohain, Neelakshi
    Shen, Xiaoying
    LaBranche, Celia
    Eaton, Amanda
    Sutherland, Laura
    Lee, Esther M.
    Hernandez, Giovanna E.
    Wu, Nelson R.
    Scearce, Richard
    Seaman, Michael S.
    Moody, M. Anthony
    Santra, Sampa
    Wiehe, Kevin
    Tomaras, Georgia D.
    Wagh, Kshitij
    Korber, Bette
    Bonsignori, Mattia
    Montefiori, David C.
    Haynes, Barton F.
    de Val, Natalia
    Joyce, M. Gordon
    Saunders, Kevin O.
    PLOS PATHOGENS, 2021, 17 (06)
  • [5] Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
    Prenafeta, Antoni
    Bech-Sabat, Gregori
    Moros, Alexandra
    Barreiro, Antonio
    Fernandez, Alex
    Canete, Manuel
    Roca, Merce
    Gonzalez-Gonzalez, Luis
    Garriga, Carme
    Confais, Joachim
    Toussenot, Marion
    Contamin, Hugues
    Pizzorno, Andres
    Rosa-Calatrava, Manuel
    Pradenas, Edwards
    Marfil, Silvia
    Blanco, Julia
    Rica, Paula Cebollada
    Sistere-Oro, Marta
    Meyerhans, Andreas
    Lorca, Cristina
    Segales, Joaquim
    Prat, Teresa
    March, Ricard
    Ferrer, Laura
    ISCIENCE, 2023, 26 (07)
  • [7] Apropos "Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates"
    Arya, Subhash C.
    Agarwal, Nirmala
    VACCINE, 2008, 26 (35) : 4413 - 4413
  • [8] Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
    Cottrell, Christopher A.
    van Schooten, Jelle
    Bowman, Charles A.
    Yuan, Meng
    Oyen, David
    Shin, Mia
    Morpurgo, Robert
    van der Woude, Patricia
    van Breemen, Marielle
    Torres, Jonathan L.
    Patel, Raj
    Gross, Justin
    Sewall, Leigh M.
    Copps, Jeffrey
    Ozorowski, Gabriel
    Nogal, Bartek
    Sok, Devin
    Rakasz, Eva G.
    Labranche, Celia
    Vigdorovich, Vladimir
    Christley, Scott
    Carnathan, Diane G.
    Sather, D. Noah
    Montefiori, David
    Silvestri, Guido
    Burton, Dennis R.
    Moore, John P.
    Wilson, Ian A.
    Sanders, Rogier W.
    Ward, Andrew B.
    van Gils, Marit J.
    PLOS PATHOGENS, 2020, 16 (08)
  • [10] The evaluation of immunological safety of the CombiHIVvac candidate vaccine against HIV-1
    Gamaley, S. G.
    Sysoeva, G. M.
    Danilenko, E. D.
    Masycheva, V. I.
    Karpenko, L. I.
    CYTOKINE, 2009, 48 (1-2) : 73 - 73